Royal Bank Of Canada Replimune Group, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Replimune Group, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 8,540 shares of REPL stock, worth $127,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,540

Previous 7,957 7.33%

Holding current value

$127,502

Previous $71,000 30.99%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.09 - $11.23 $4,716 - $6,547	583 Added 7.33%	8,540 $93,000
Q2 2024 Aug 14, 2024	BUY	$5.01 - $9.46 $20,335 - $38,398	4,059 Added 104.13%	7,957 $71,000
Q1 2024 Nov 05, 2024	SELL	$6.87 - $9.31 $27,885 - $37,789	-4,059 Reduced 51.01%	3,898 $31,000
Q1 2024 May 15, 2024	SELL	$6.87 - $9.31 $105,914 - $143,532	-15,417 Reduced 79.82%	3,898 $31,000
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $67,682 - $162,236	10,027 Added 107.96%	19,315 $162,000
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $206,761 - $287,341	-12,955 Reduced 58.24%	9,288 $158,000
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $152,634 - $235,047	9,753 Added 78.09%	22,243 $516,000
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $97,258 - $161,856	5,564 Added 80.33%	12,490 $220,000
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $70,376 - $114,933	4,118 Added 146.65%	6,926 $188,000
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $5,054 - $6,852	324 Added 13.04%	2,808 $49,000
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $22,444 - $33,666	-1,685 Reduced 40.42%	2,484 $43,000
Q1 2022 May 16, 2022	SELL	$15.24 - $29.75 $58,094 - $113,407	-3,812 Reduced 47.76%	4,169 $70,000
Q4 2021 Feb 14, 2022	BUY	$25.43 - $34.25 $80,791 - $108,812	3,177 Added 66.13%	7,981 $217,000
Q3 2021 Nov 15, 2021	BUY	$28.98 - $39.54 $19,039 - $25,977	657 Added 15.84%	4,804 $143,000
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $118,189 - $163,267	4,147 New	4,147 $159,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $736M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Replimune Group, Inc. Transaction History